Design of tailor-made prodrugs for tumor-selective therapy by Glüsenkamp, K. -H., Mengede, C., Drosdziok, W., Johnen, R., Krüsemann, C., Bitzenhofer, U., Jähde, E., Rajewsky, M. F.

Get full text

The Swiss National Registry for Primary Immunodeficiencies: report on the first 6 years’ activity from 2008 to 2014 by Marschall, K., Hoernes, M., Bitzenhofer‐Grüber, M., Jandus, P., Duppenthaler, A., Wuillemin, W. A., Rischewski, J., Boyman, O., Heininger, U., Hauser, T., Steiner, U., Posfay‐Barbe, K., Seebach, J., Recher, M., Hess, C., Helbling, A., Reichenbach, J.

Get full text

Production of tailored hydroxylated prodiginine showing combinatorial activity with rhamnolipids against plant-parasitic nematodes by Kossmann, D F, Huang, M, Weihmann, R, Xiao, X, Gätgens, F, Weber, T M, Brass, H U C, Bitzenhofer, N L, Ibrahim, S, Bangert, K, Rehling, L, Mueller, C, Tiso, T, Blank, L M, Drepper, T, Jaeger, K-E, Grundler, F M W, Pietruszka, J, Schleker, A S S, Loeschcke, A

Get full text

An increase in serum tryptase even below 11.4 ng/mL may indicate a mast cell-mediated hypersensitivity reaction: a prospective study in Hymenoptera venom allergic patients by Borer-Reinhold, M., Haeberli, G., Bitzenhofer, M., Jandus, P., Hausmann, O., Fricker, M., Helbling, A., Müller, U.

Get full text

An increase in serum tryptase even below 11.4 ng/mL may indicate a mast cell‐mediated hypersensitivity reaction: a prospective study in H ymenoptera venom allergic patients by Borer‐Reinhold, M., Haeberli, G., Bitzenhofer, M., Jandus, P., Hausmann, O., Fricker, M., Helbling, A., Müller, U.

Get full text